NYSE$OHI
Omega Healthcare Investors Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Omega Healthcare reported Q3 2024 results, completed $834 million in new investments year-to-date, and increased full year adjusted FFO guidance.
Omega Healthcare Investors, Inc. announced its Q3 2024 results, featuring a net income of $115 million, or $0.42 per common share, and adjusted Funds From Operations (FFO) of $203 million, or $0.74 per common share. The company completed $440 million in new investments during the quarter and increased its full-year AFFO guidance to $2.84 to $2.86 per share.
- Net income for the quarter was $115 million, or $0.42 per common share.
- Nareit Funds From Operations (FFO) for the quarter was $196 million, or $0.71 per common share.
- Adjusted Funds From Operations (AFFO) for the quarter was $203 million, or $0.74 per common share.
- Completed $440 million in new investments in Q3, including real estate acquisitions and loans.
Headline financials
Revenue & EPS history
Omega Healthcare · Revenue · Quarterly
$276M
Revenue by segment
Omega Healthcare · $31.8M total across 3 segments · Q3 2023
- Real estate loans interest income$24.9M—78.2%
- Non-real estate loans interest income$5.73M—18.0%
- Miscellaneous income$1.21M+398.8%3.8%
Forward guidance
The Company increased its expected 2024 Adjusted FFO range to be between $2.84 to $2.86 per diluted share from the previous range of $2.78 to $2.84 per diluted share.
Tailwinds
- Includes the annual impact of $834 million in new investments completed through October 2024.
- Includes $31 million in asset sales related to a portion of the $76 million in facilities classified as held for sale.
- Considers fourth quarter G&A expense of approximately $11.5 million to $13.5 million.
- Assumes no material changes in market interest rates.
- Assumes no additional operators are placed on a cash-basis for revenue recognition.
Headwinds
- Excludes any additional acquisitions and asset sales.
- Excludes certain revenue and expense items.
- Excludes interest refinancing expenses.
- Excludes acquisition costs.
- Excludes capital market activity and additional provisions for credit losses, if any.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
-0.1%
Avg return
Earnings day
+0.2%
Avg return
5 days after
+2.4%
Avg return
30 days after
49%
33 / 68 earnings
Positive
+13.1%
Q1 2022
Best reaction
-9.1%
Q3 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.0% | -2.6% | -1.3% | |
| Q4 2025 | +6.1% | +5.8% | +11.0% | |
| Q3 2025 | +5.3% | +7.9% | +15.2% | |
| Q1 2025 | -4.1% | -7.5% | -4.0% | |
| Q4 2024 | -0.7% | -6.0% | -3.7% | |
| Q3 2024 | +1.4% | -4.5% | -3.0% | |
| Q2 2024 | +5.1% | +1.8% | +8.6% | |
| Q1 2024 | +2.1% | +0.8% | +5.3% | |
| Q4 2023 | +6.9% | +10.2% | +9.9% | |
| Q3 2023 | -5.2% | -5.8% | -3.4% | |
| Q2 2023 | -1.1% | +1.0% | +3.2% | |
| Q1 2023 | +8.5% | +7.9% | +10.4% | |
| Q4 2022 | -2.2% | -5.1% | -7.9% | |
| Q3 2022 | -1.3% | +2.5% | -5.1% | |
| Q2 2022 | +1.8% | +3.2% | +5.4% | |
| Q1 2022 | +13.1% | +11.3% | +15.9% | |
| Q4 2021 | -8.4% | -11.2% | -8.7% | |
| Q3 2021 | +0.2% | -4.7% | -7.6% | |
| Q2 2021 | -4.6% | -3.2% | -6.9% | |
| Q1 2021 | -2.0% | -3.9% | -0.1% | |
| Q4 2020 | -0.6% | -1.2% | +1.2% | |
| Q3 2020 | -1.1% | +3.8% | +23.1% | |
| Q2 2020 | +3.0% | +4.8% | -0.2% | |
| Q1 2020 | +0.0% | +1.8% | +21.9% | |
| Q4 2019 | -0.0% | +1.4% | -7.7% | |
| Q3 2019 | -2.2% | -5.4% | -2.6% | |
| Q2 2019 | +1.5% | +7.8% | +15.4% | |
| Q1 2019 | +1.5% | +4.3% | +2.3% | |
| Q4 2018 | -5.9% | -6.9% | -6.5% | |
| Q3 2018 | +5.2% | +7.5% | +15.6% | |
| Q2 2018 | +3.7% | +5.5% | +10.9% | |
| Q1 2018 | +3.4% | +7.0% | +13.1% | |
| Q4 2017 | -2.9% | +1.4% | +3.7% | |
| Q3 2017 | -9.1% | -10.6% | -15.6% | |
| Q2 2017 | -3.4% | -4.9% | -5.8% | |
| Q1 2017 | -2.6% | -0.8% | -3.3% | |
| Q4 2016 | -5.0% | -1.8% | -3.7% | |
| Q3 2016 | -1.7% | -6.5% | -5.8% | |
| Q2 2016 | +1.5% | +1.9% | +3.5% | |
| Q1 2016 | -1.2% | — | — | |
| Q4 2015 | +4.4% | — | — | |
| Q3 2015 | -0.5% | — | — | |
| Q2 2015 | +1.2% | — | — | |
| Q1 2015 | -3.5% | — | — | |
| Q4 2014 | -0.7% | — | — | |
| Q3 2014 | +1.8% | — | — | |
| Q2 2014 | +0.1% | — | — | |
| Q1 2014 | -0.6% | — | — | |
| Q4 2013 | -1.4% | — | — | |
| Q3 2013 | -2.0% | — | — | |
| Q2 2013 | -7.3% | — | — | |
| Q1 2013 | +0.5% | — | — | |
| Q4 2012 | +4.2% | — | — | |
| Q3 2012 | -3.0% | — | — | |
| Q2 2012 | +1.1% | — | — | |
| Q1 2012 | +0.4% | — | — | |
| Q4 2011 | -1.8% | — | — | |
| Q3 2011 | +2.2% | — | — | |
| Q2 2011 | +3.2% | — | — | |
| Q1 2010 | +0.1% | — | — | |
| Q1 2011 | +1.3% | — | — | |
| Q4 2008 | -2.2% | — | — | |
| Q4 2010 | -2.2% | — | — | |
| Q3 2010 | -4.4% | — | — | |
| Q3 2009 | -4.4% | — | — | |
| Q2 2009 | +1.3% | — | — | |
| Q2 2010 | +1.3% | — | — | |
| Q4 2009 | +1.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro